Bahl & Gaynor Inc Merck & Co., Inc. Transaction History
Bahl & Gaynor Inc
- $19.3 Billion
- Q3 2024
A detailed history of Bahl & Gaynor Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Bahl & Gaynor Inc holds 4,431,001 shares of MRK stock, worth $446 Million. This represents 2.61% of its overall portfolio holdings.
Number of Shares
4,431,001
Previous 4,262,313
3.96%
Holding current value
$446 Million
Previous $528 Million
4.64%
% of portfolio
2.61%
Previous 2.95%
Shares
32 transactions
Others Institutions Holding MRK
# of Institutions
3,824Shares Held
1.88BCall Options Held
15.6MPut Options Held
13.7M-
Vanguard Group Inc Valley Forge, PA250MShares$25.1 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$20.9 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$12 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$7.63 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.95 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $255B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...